Bath & Body Works, Inc. (NYSE:BBWI - Get Free Report) announced a quarterly dividend on Friday, November 8th,Zacks Dividends reports. Shareholders of record on Friday, November 22nd will be given a dividend of 0.20 per share on Friday, December 6th. This represents a $0.80 dividend on an annualized basis and a dividend yield of 2.67%. The ex-dividend date is Friday, November 22nd.
Bath & Body Works has increased its dividend payment by an average of 38.7% annually over the last three years. Bath & Body Works has a dividend payout ratio of 22.3% indicating that its dividend is sufficiently covered by earnings. Equities analysts expect Bath & Body Works to earn $3.62 per share next year, which means the company should continue to be able to cover its $0.80 annual dividend with an expected future payout ratio of 22.1%.
Bath & Body Works Price Performance
Shares of NYSE:BBWI traded down $1.75 during trading on Friday, hitting $30.00. The company's stock had a trading volume of 9,932,695 shares, compared to its average volume of 4,421,947. The firm has a market cap of $6.57 billion, a price-to-earnings ratio of 7.26, a P/E/G ratio of 1.01 and a beta of 1.79. The company has a 50-day moving average of $30.01 and a 200-day moving average of $36.93. Bath & Body Works has a 12 month low of $26.20 and a 12 month high of $52.99.
Bath & Body Works (NYSE:BBWI - Get Free Report) last released its quarterly earnings results on Wednesday, August 28th. The company reported $0.37 earnings per share for the quarter, topping the consensus estimate of $0.35 by $0.02. Bath & Body Works had a net margin of 12.69% and a negative return on equity of 41.94%. The business had revenue of $1.53 billion for the quarter, compared to the consensus estimate of $1.54 billion. As a group, research analysts anticipate that Bath & Body Works will post 3.18 earnings per share for the current year.
Insider Activity at Bath & Body Works
In other Bath & Body Works news, CEO Gina Boswell purchased 6,000 shares of the stock in a transaction that occurred on Wednesday, October 9th. The stock was purchased at an average price of $29.64 per share, with a total value of $177,840.00. Following the acquisition, the chief executive officer now owns 242,987 shares in the company, valued at approximately $7,202,134.68. The trade was a 0.00 % increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. 0.27% of the stock is owned by insiders.
Wall Street Analysts Forecast Growth
Several equities analysts have weighed in on the stock. Citigroup lowered their price target on shares of Bath & Body Works from $48.00 to $35.00 and set a "neutral" rating on the stock in a report on Tuesday, August 20th. Barclays cut shares of Bath & Body Works from an "equal weight" rating to an "underweight" rating and lowered their target price for the company from $31.00 to $28.00 in a research note on Friday. The Goldman Sachs Group cut their price target on Bath & Body Works from $60.00 to $49.00 and set a "buy" rating for the company in a research note on Thursday, August 29th. Wells Fargo & Company lowered their price objective on Bath & Body Works from $35.00 to $32.00 and set an "equal weight" rating on the stock in a research report on Wednesday. Finally, Morgan Stanley dropped their price objective on Bath & Body Works from $56.00 to $51.00 and set an "overweight" rating for the company in a research note on Thursday, September 5th. One equities research analyst has rated the stock with a sell rating, six have assigned a hold rating and nine have assigned a buy rating to the company. Based on data from MarketBeat.com, Bath & Body Works currently has a consensus rating of "Moderate Buy" and a consensus target price of $42.44.
View Our Latest Stock Analysis on Bath & Body Works
About Bath & Body Works
(
Get Free Report)
Bath & Body Works, Inc operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. It sells its products under the Bath & Body Works, White Barn, and other brand names through retail stores and e-commerce sites located in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale arrangements.
See Also
Before you consider Bath & Body Works, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bath & Body Works wasn't on the list.
While Bath & Body Works currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Options trading isn’t just for the Wall Street elite; it’s an accessible strategy for anyone armed with the proper knowledge. Think of options as a strategic toolkit, with each tool designed for a specific financial task. Keep reading to learn how options trading can help you use the market’s volatility to your advantage.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.